NIK inhibitors (Harbin Institute of Technology/Chinese Academy of Sciences/Nanjing University of Chinese Medicine)

N/A

Report date: 2025/01/26 16:38:02
NME

Base Information

Drug NameNIK inhibitors (Harbin Institute of Technology/Chinese Academy of Sciences/Nanjing University of Chinese Medicine)
Drug Alias NameXT-2
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMitogen-Activated Protein Kinase Kinase Kinase 14 inhibitors
TargetsMitogen-Activated Protein Kinase Kinase Kinase 14
Therapy Area/IndicationsInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesHarbin Institute Of Technology
China Registration ClassN/A

Develop Information

Active CompaniesChinese Academy Of SciencesHarbin Institute Of TechnologyNanjing University Of Chinese Medicine
Inactive CompaniesN/A
Active IndicationsInflammation
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A